Equity Details
Price & Market Data
Price: $0.848
Daily Change: +$0.108 / 12.69%
Daily Range: $0.634 - $0.89
Market Cap: $27,664,264
Daily Volume: 216,758
Performance Metrics
1 Week: 4.05%
1 Month: -5.98%
3 Months: -5.29%
6 Months: -16.30%
1 Year: -26.67%
YTD: -21.39%
About Dyadic International, Inc. (DYAI)
Stay informed about Dyadic International, Inc. (DYAI)'s market activity. The stock is holding at 0.848, showing a daily change of +$0.108 / 12.69%. Its market capitalization reaches 27,664,264. Performance metrics include YTD (-21.39%) and various other periods like 1-week and 6-month returns.
Company Details
Employees: 5
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.